Intellectual property policy on pharmaceutical products: a view in the beginning of the 2000 decade

Authors

  • Sergio M. Paulino de Carvalho Instituto Nacional de Propriedade Intelectual, Centro, Rio de Janeiro, RJ, Brasil
  • Sergio Salles-Filho Universidade Estadual de Campinas, Departamento de Política Científica e Tecnológica, Campinas, SP, Brasil
  • Marcos Paulo Fuck Universidade Estadual de Campinas, Departamento de Política Científica e Tecnológica, Campinas, SP, Brasil
  • Maria Beatriz Bonacelli Universidade Estadual de Campinas, Departamento de Política Científica e Tecnológica, Campinas, SP, Brasil
  • Antonio Márcio Buainain Universidade Estadual de Campinas, Instituto de Economia, Campinas, SP, Brasil

DOI:

https://doi.org/10.3395/reciis.v2i2.850

Keywords:

Intellectual property, policy, health, pharmaceutical products

Abstract

This paper aims at an analysis of the intellectual property policy in the health field by emphasizing the program of production and distribution of antiretrovirals and the generic drugs market, also reviewing the process of articulation and implementation of the intellectual property policy in this sector. From a methodological viewpoint, the paper favors the analysis of data related to the structuring of the pharmaceutical products market and of impacts both from the new institutionality and the intellectual property policies developed by the Ministry of Health in the first half of the 2000’s decade.

Published

2008-07-01

How to Cite

de Carvalho, S. M. P., Salles-Filho, S., Fuck, M. P., Bonacelli, M. B., & Buainain, A. M. (2008). Intellectual property policy on pharmaceutical products: a view in the beginning of the 2000 decade. Revista Eletrônica De Comunicação, Informação & Inovação Em Saúde, 2(2). https://doi.org/10.3395/reciis.v2i2.850

Issue

Section

Review Articles